speb/financial-data huggingface dataset:
CDXS income_statement (annual, 2024-12-31) — Interest Expense: 10393000.00
CDXS income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 10393000.00
CDXS income_statement (annual, 2024-12-31) — Interest Income: 3670000.00
CDXS income_statement (annual, 2024-12-31) — Interest Income Non Operating: 3670000.00
CDXS cash_flow (annual, 2024-12-31) — Interest Paid Supplemental Data: 2566000.00
CDXS balance_sheet (annual, 2024-12-31) — Inventory: 1799000.00
CDXS balance_sheet (annual, 2024-12-31) — Invested Capital: 95832000.00
CDXS cash_flow (annual, 2024-12-31) — Investing Cash Flow: -56980000.00
CDXS balance_sheet (annual, 2024-12-31) — Investmentin Financial Assets: 2798000.00
CDXS balance_sheet (annual, 2024-12-31) — Investments And Advances: 2798000.00
CDXS cash_flow (annual, 2024-12-31) — Issuance Of Capital Stock: 31319000.00
CDXS cash_flow (quarterly, 2024-12-31) — Issuance Of Capital Stock: -1000.00
CDXS cash_flow (annual, 2024-12-31) — Issuance Of Debt: 29521000.00
CDXS cash_flow (quarterly, 2024-12-31) — Issuance Of Debt: 0.00
CDXS balance_sheet (annual, 2024-12-31) — Leases: 12159000.00
CDXS balance_sheet (annual, 2024-12-31) — Long Term Capital Lease Obligation: 28163000.00
CDXS balance_sheet (annual, 2024-12-31) — Long Term Debt: 28905000.00
CDXS balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 57068000.00
CDXS cash_flow (annual, 2024-12-31) — Long Term Debt Issuance: 29521000.00
CDXS cash_flow (quarterly, 2024-12-31) — Long Term Debt Issuance: 0.00
CDXS balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 3583000.00
CDXS cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: 31319000.00
CDXS cash_flow (quarterly, 2024-12-31) — Net Common Stock Issuance: -1000.00
CDXS balance_sheet (annual, 2024-12-31) — Net Debt: 9641000.00
CDXS balance_sheet (quarterly, 2024-12-31) — Net Debt: 9641000.00
CDXS income_statement (annual, 2024-12-31) — Net Income: -65276000.00
CDXS income_statement (annual, 2024-12-31) — Net Income Common Stockholders: -65276000.00
CDXS income_statement (annual, 2024-12-31) — Net Income Continuous Operations: -65276000.00
CDXS income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: -65276000.00
CDXS income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: -65276000.00
CDXS cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: -65276000.00
CDXS income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: -65276000.00
CDXS income_statement (annual, 2024-12-31) — Net Interest Income: -6723000.00
CDXS cash_flow (annual, 2024-12-31) — Net Investment Purchase And Sale: -52762000.00
CDXS cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: 29521000.00
CDXS cash_flow (quarterly, 2024-12-31) — Net Issuance Payments Of Debt: 0.00
CDXS cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: 29521000.00
CDXS cash_flow (quarterly, 2024-12-31) — Net Long Term Debt Issuance: 0.00
CDXS income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: -6723000.00
CDXS cash_flow (annual, 2024-12-31) — Net Other Financing Charges: -2348000.00
CDXS balance_sheet (annual, 2024-12-31) — Net PPE: 42897000.00
CDXS cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -4218000.00
CDXS balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 64464000.00
CDXS balance_sheet (annual, 2024-12-31) — Non Current Deferred Liabilities: 100000.00
CDXS balance_sheet (annual, 2024-12-31) — Non Current Deferred Revenue: 100000.00
CDXS income_statement (annual, 2024-12-31) — Normalized EBITDA: -49738000.00
CDXS income_statement (annual, 2024-12-31) — Normalized Income: -65145650.00
CDXS cash_flow (annual, 2024-12-31) — Operating Cash Flow: -49410000.00
CDXS income_statement (annual, 2024-12-31) — Operating Income: -58354000.00
CDXS income_statement (annual, 2024-12-31) — Operating Revenue: 59345000.00
CDXS balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 81850000.00
CDXS balance_sheet (annual, 2024-12-31) — Other Current Assets: 4128000.00
CDXS balance_sheet (annual, 2024-12-31) — Other Equity Adjustments: 52000.00
CDXS income_statement (annual, 2024-12-31) — Other Income Expense: -165000.00
CDXS income_statement (quarterly, 2024-12-31) — Other Income Expense: -10393000.00
CDXS cash_flow (annual, 2024-12-31) — Other Non Cash Items: 881000.00
CDXS balance_sheet (annual, 2024-12-31) — Other Non Current Assets: 2081000.00
CDXS balance_sheet (annual, 2024-12-31) — Other Non Current Liabilities: 1268000.00
CDXS income_statement (annual, 2024-12-31) — Other Non Operating Income Expenses: -10393000.00
CDXS balance_sheet (annual, 2024-12-31) — Other Properties: 64649000.00
CDXS balance_sheet (annual, 2024-12-31) — Other Receivables: 7126000.00
CDXS balance_sheet (annual, 2024-12-31) — Other Short Term Investments: 54194000.00
CDXS balance_sheet (annual, 2024-12-31) — Payables: 2838000.00
CDXS balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 9061000.00
CDXS balance_sheet (annual, 2024-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 11410000.00
CDXS balance_sheet (annual, 2024-12-31) — Preferred Stock: 0.00
CDXS income_statement (annual, 2024-12-31) — Pretax Income: -65242000.00
CDXS cash_flow (annual, 2024-12-31) — Proceeds From Stock Option Exercised: 2030000.00
CDXS balance_sheet (annual, 2024-12-31) — Properties: 0.00
CDXS cash_flow (annual, 2024-12-31) — Provisionand Write Offof Assets: 97000.00
CDXS cash_flow (annual, 2024-12-31) — Purchase Of Investment: -90235000.00
CDXS cash_flow (annual, 2024-12-31) — Purchase Of PPE: -4305000.00
CDXS balance_sheet (annual, 2024-12-31) — Raw Materials: 0.00
CDXS balance_sheet (quarterly, 2024-12-31) — Raw Materials: 0.00
CDXS balance_sheet (annual, 2024-12-31) — Receivables: 18884000.00
CDXS balance_sheet (annual, 2024-12-31) — Receivables Adjustments Allowances: -162000.00
CDXS income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 16288000.00
CDXS income_statement (annual, 2024-12-31) — Reconciled Depreciation: 4946000.00
CDXS income_statement (annual, 2024-12-31) — Research And Development: 46263000.00
CDXS balance_sheet (annual, 2024-12-31) — Restricted Cash: 503000.00
CDXS income_statement (annual, 2024-12-31) — Restructuring And Mergern Acquisition: 0.00
CDXS income_statement (quarterly, 2024-12-31) — Restructuring And Mergern Acquisition: 0.00
CDXS balance_sheet (annual, 2024-12-31) — Retained Earnings: -562806000.00
CDXS cash_flow (annual, 2024-12-31) — Sale Of Investment: 37473000.00
CDXS cash_flow (annual, 2024-12-31) — Sale Of PPE: 87000.00
CDXS cash_flow (quarterly, 2024-12-31) — Sale Of PPE: 3000.00
CDXS income_statement (annual, 2024-12-31) — Selling General And Administration: 55148000.00
CDXS balance_sheet (annual, 2024-12-31) — Share Issued: 81850000.00
CDXS income_statement (annual, 2024-12-31) — Special Income Charges: -165000.00
CDXS income_statement (quarterly, 2024-12-31) — Special Income Charges: 0.00
CDXS cash_flow (annual, 2024-12-31) — Stock Based Compensation: 13087000.00
CDXS balance_sheet (annual, 2024-12-31) — Stockholders Equity: 66927000.00
CDXS balance_sheet (annual, 2024-12-31) — Tangible Book Value: 64464000.00
CDXS income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: -34650.00
CDXS income_statement (annual, 2024-12-31) — Tax Provision: 34000.00
CDXS income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.21
CDXS balance_sheet (annual, 2024-12-31) — Total Assets: 149011000.00
CDXS balance_sheet (annual, 2024-12-31) — Total Capitalization: 95832000.00
CDXS balance_sheet (annual, 2024-12-31) — Total Debt: 59895000.00
CDXS balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 66927000.00
CDXS income_statement (annual, 2024-12-31) — Total Expenses: 117699000.00
CDXS balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 82084000.00
CDXS balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 50239000.00
CDXS balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 58436000.00
CDXS income_statement (annual, 2024-12-31) — Total Operating Income As Reported: -58519000.00
CDXS income_statement (annual, 2024-12-31) — Total Unusual Items: -165000.00
CDXS income_statement (quarterly, 2024-12-31) — Total Unusual Items: 0.00
CDXS income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: -165000.00
CDXS income_statement (quarterly, 2024-12-31) — Total Unusual Items Excluding Goodwill: 0.00
CDXS cash_flow (annual, 2024-12-31) — Unrealized Gain Loss On Investment Securities: 0.00
CDXS balance_sheet (annual, 2024-12-31) — Work In Process: 29000.00
CDXS balance_sheet (annual, 2024-12-31) — Working Capital: 75124000.00
CDXS income_statement (quarterly, 2025-03-31) — +Operating Expense: 25297000.00
CDXS income_statement (quarterly, 2025-03-31) — +Total Revenue: 7543000.00
CDXS balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 6046000.00
CDXS balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 6442000.00
CDXS balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -41572000.00
CDXS balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 633101000.00
CDXS cash_flow (quarterly, 2025-03-31) — Amortization Of Securities: -330000.00
CDXS balance_sheet (quarterly, 2025-03-31) — Available For Sale Securities: 2798000.00
CDXS income_statement (quarterly, 2025-03-31) — Basic Average Shares: 82410000.00
CDXS income_statement (quarterly, 2025-03-31) — Basic EPS: -0.25
CDXS cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 20829000.00
CDXS cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -1255000.00
CDXS balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 30311000.00
CDXS balance_sheet (quarterly, 2025-03-31) — Capital Stock: 8000.00
CDXS balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 18319000.00
CDXS balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 59781000.00
CDXS balance_sheet (quarterly, 2025-03-31) — Cash Equivalents: 13928000.00
CDXS balance_sheet (quarterly, 2025-03-31) — Cash Financial: 4391000.00
CDXS cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: 1085000.00
CDXS cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: 11769000.00
CDXS cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: -13798000.00
CDXS cash_flow (quarterly, 2025-03-31) — Change In Account Payable: 2065000.00
CDXS cash_flow (quarterly, 2025-03-31) — Change In Inventory: 18000.00
CDXS cash_flow (quarterly, 2025-03-31) — Change In Other Current Assets: 7426000.00
CDXS cash_flow (quarterly, 2025-03-31) — Change In Other Current Liabilities: -750000.00
CDXS cash_flow (quarterly, 2025-03-31) — Change In Other Working Capital: -6023000.00
CDXS cash_flow (quarterly, 2025-03-31) — Change In Payable: 2065000.00
CDXS cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: 2065000.00
CDXS cash_flow (quarterly, 2025-03-31) — Change In Prepaid Assets: 31000.00
CDXS cash_flow (quarterly, 2025-03-31) — Change In Working Capital: 2767000.00
CDXS cash_flow (quarterly, 2025-03-31) — Changes In Cash: -944000.00
CDXS balance_sheet (quarterly, 2025-03-31) — Common Stock: 8000.00
CDXS balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 49629000.00
CDXS balance_sheet (quarterly, 2025-03-31) — Construction In Progress: 3223000.00
CDXS income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 2732000.00
CDXS balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 5117000.00
CDXS balance_sheet (quarterly, 2025-03-31) — Current Assets: 77808000.00
CDXS balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 2913000.00
CDXS balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 2913000.00
CDXS balance_sheet (quarterly, 2025-03-31) — Current Deferred Liabilities: 438000.00
CDXS balance_sheet (quarterly, 2025-03-31) — Current Deferred Revenue: 438000.00
CDXS balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 20901000.00
CDXS cash_flow (quarterly, 2025-03-31) — Depreciation: 1909000.00
CDXS cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 1909000.00
CDXS cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 1909000.00
CDXS income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 82410000.00
CDXS income_statement (quarterly, 2025-03-31) — Diluted EPS: -0.25
CDXS income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: -20688000.00
CDXS income_statement (quarterly, 2025-03-31) — EBIT: -19735000.00
CDXS income_statement (quarterly, 2025-03-31) — EBITDA: -17826000.00
CDXS cash_flow (quarterly, 2025-03-31) — End Cash Position: 19885000.00
CDXS cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: 1085000.00
CDXS balance_sheet (quarterly, 2025-03-31) — Finished Goods: 1781000.00
CDXS cash_flow (quarterly, 2025-03-31) — Free Cash Flow: -15053000.00
CDXS balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: 14000.00
CDXS balance_sheet (quarterly, 2025-03-31) — Goodwill: 2463000.00
CDXS balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 2463000.00
CDXS balance_sheet (quarterly, 2025-03-31) — Gross PPE: 85361000.00
CDXS income_statement (quarterly, 2025-03-31) — Gross Profit: 4811000.00
CDXS cash_flow (quarterly, 2025-03-31) — Income Tax Paid Supplemental Data: 0.00
CDXS income_statement (quarterly, 2025-03-31) — Interest Expense: 942000.00
CDXS income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 942000.00
CDXS income_statement (quarterly, 2025-03-31) — Interest Income: 751000.00
CDXS income_statement (quarterly, 2025-03-31) — Interest Income Non Operating: 751000.00
CDXS cash_flow (quarterly, 2025-03-31) — Interest Paid Supplemental Data: 432000.00
CDXS balance_sheet (quarterly, 2025-03-31) — Inventory: 1781000.00
CDXS balance_sheet (quarterly, 2025-03-31) — Invested Capital: 78815000.00
CDXS cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: 11769000.00
CDXS balance_sheet (quarterly, 2025-03-31) — Investmentin Financial Assets: 2798000.00
CDXS balance_sheet (quarterly, 2025-03-31) — Investments And Advances: 2798000.00
CDXS cash_flow (quarterly, 2025-03-31) — Issuance Of Debt: 0.00
CDXS balance_sheet (quarterly, 2025-03-31) — Leases: 14256000.00
CDXS balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 27398000.00
CDXS balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 29186000.00
CDXS balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 56584000.00
CDXS cash_flow (quarterly, 2025-03-31) — Long Term Debt Issuance: 0.00
CDXS balance_sheet (quarterly, 2025-03-31) — Machinery Furniture Equipment: 3698000.00
CDXS balance_sheet (quarterly, 2025-03-31) — Net Debt: 10867000.00
CDXS income_statement (quarterly, 2025-03-31) — Net Income: -20688000.00
CDXS income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: -20688000.00
CDXS income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: -20688000.00
CDXS income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: -20688000.00
CDXS income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: -20688000.00
CDXS cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: -20688000.00
CDXS income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: -20688000.00
CDXS income_statement (quarterly, 2025-03-31) — Net Interest Income: -191000.00
CDXS cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: 13024000.00
CDXS cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: 0.00
CDXS cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: 0.00
CDXS income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -191000.00
CDXS cash_flow (quarterly, 2025-03-31) — Net Other Financing Charges: -13000.00
CDXS balance_sheet (quarterly, 2025-03-31) — Net PPE: 43789000.00
CDXS cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -1255000.00
CDXS balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 47166000.00
CDXS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Liabilities: 490000.00
CDXS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Revenue: 490000.00
CDXS income_statement (quarterly, 2025-03-31) — Normalized EBITDA: -17826000.00
CDXS income_statement (quarterly, 2025-03-31) — Normalized Income: -20688000.00
CDXS cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: -13798000.00
CDXS income_statement (quarterly, 2025-03-31) — Operating Income: -20486000.00
CDXS income_statement (quarterly, 2025-03-31) — Operating Revenue: 7543000.00
CDXS balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 82841000.00
CDXS balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 4155000.00
CDXS balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: 14000.00
CDXS cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: 278000.00
CDXS balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 2029000.00
CDXS balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 1283000.00
CDXS balance_sheet (quarterly, 2025-03-31) — Other Properties: 64184000.00
CDXS balance_sheet (quarterly, 2025-03-31) — Other Receivables: 5194000.00
CDXS balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 41462000.00
CDXS balance_sheet (quarterly, 2025-03-31) — Payables: 6046000.00
CDXS balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 11163000.00
CDXS balance_sheet (quarterly, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 6387000.00
CDXS balance_sheet (quarterly, 2025-03-31) — Preferred Stock: 0.00
CDXS income_statement (quarterly, 2025-03-31) — Pretax Income: -20677000.00
CDXS cash_flow (quarterly, 2025-03-31) — Proceeds From Stock Option Exercised: 1098000.00
CDXS balance_sheet (quarterly, 2025-03-31) — Properties: 0.00
CDXS cash_flow (quarterly, 2025-03-31) — Provisionand Write Offof Assets: -113000.00
CDXS cash_flow (quarterly, 2025-03-31) — Purchase Of Investment: -10326000.00
CDXS cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -1255000.00
CDXS balance_sheet (quarterly, 2025-03-31) — Receivables: 11587000.00
CDXS balance_sheet (quarterly, 2025-03-31) — Receivables Adjustments Allowances: -49000.00
CDXS income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 2732000.00
CDXS income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 1909000.00
CDXS income_statement (quarterly, 2025-03-31) — Research And Development: 12942000.00
CDXS balance_sheet (quarterly, 2025-03-31) — Restricted Cash: 504000.00
CDXS balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -583494000.00
CDXS cash_flow (quarterly, 2025-03-31) — Sale Of Investment: 23350000.00
CDXS cash_flow (quarterly, 2025-03-31) — Sale Of PPE: 1000.00
CDXS income_statement (quarterly, 2025-03-31) — Selling General And Administration: 12355000.00
CDXS balance_sheet (quarterly, 2025-03-31) — Share Issued: 82841000.00
CDXS cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 2379000.00
CDXS balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 49629000.00
CDXS balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 47166000.00
CDXS income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
CDXS income_statement (quarterly, 2025-03-31) — Tax Provision: 11000.00
CDXS income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.21
CDXS balance_sheet (quarterly, 2025-03-31) — Total Assets: 128887000.00
CDXS balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 78815000.00
CDXS balance_sheet (quarterly, 2025-03-31) — Total Debt: 59497000.00
CDXS balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 49629000.00
CDXS income_statement (quarterly, 2025-03-31) — Total Expenses: 28029000.00
CDXS balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 79258000.00
CDXS balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 51079000.00
CDXS balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 58357000.00
CDXS income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: -20486000.00
CDXS balance_sheet (quarterly, 2025-03-31) — Work In Process: 0.00
CDXS balance_sheet (quarterly, 2025-03-31) — Working Capital: 56907000.00
CDXS income_statement (quarterly, 2025-06-30) — +Operating Expense: 26092000.00
CDXS income_statement (quarterly, 2025-06-30) — +Total Revenue: 15328000.00
CDXS balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 1468000.00
CDXS balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 12271000.00
CDXS balance_sheet (quarterly, 2025-06-30) — Accumulated Depreciation: -42778000.00
CDXS balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 652391000.00
CDXS cash_flow (quarterly, 2025-06-30) — Amortization Of Securities: -267000.00
CDXS balance_sheet (quarterly, 2025-06-30) — Available For Sale Securities: 2798000.00
CDXS income_statement (quarterly, 2025-06-30) — Basic Average Shares: 85389000.00
CDXS income_statement (quarterly, 2025-06-30) — Basic EPS: -0.16
CDXS cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 19885000.00
CDXS cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -2514000.00
CDXS balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 29607000.00
CDXS balance_sheet (quarterly, 2025-06-30) — Capital Stock: 9000.00
CDXS balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 26761000.00
CDXS balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 66330000.00
CDXS balance_sheet (quarterly, 2025-06-30) — Cash Equivalents: 15969000.00
CDXS balance_sheet (quarterly, 2025-06-30) — Cash Financial: 10792000.00
CDXS cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: 26774000.00
CDXS cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -367000.00
CDXS cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: -17967000.00
CDXS cash_flow (quarterly, 2025-06-30) — Change In Account Payable: -3463000.00
CDXS cash_flow (quarterly, 2025-06-30) — Change In Inventory: -164000.00
CDXS cash_flow (quarterly, 2025-06-30) — Change In Other Current Assets: -4786000.00
CDXS cash_flow (quarterly, 2025-06-30) — Change In Other Current Liabilities: -776000.00
CDXS cash_flow (quarterly, 2025-06-30) — Change In Other Working Capital: -505000.00
CDXS cash_flow (quarterly, 2025-06-30) — Change In Payable: -3463000.00
CDXS cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: -3463000.00
CDXS cash_flow (quarterly, 2025-06-30) — Change In Prepaid Assets: 374000.00
CDXS cash_flow (quarterly, 2025-06-30) — Change In Working Capital: -9320000.00
CDXS cash_flow (quarterly, 2025-06-30) — Changes In Cash: 8440000.00
CDXS balance_sheet (quarterly, 2025-06-30) — Common Stock: 9000.00
CDXS balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 55631000.00
CDXS balance_sheet (quarterly, 2025-06-30) — Construction In Progress: 1002000.00
CDXS income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 2098000.00
CDXS balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 3406000.00
CDXS balance_sheet (quarterly, 2025-06-30) — Current Assets: 88729000.00
CDXS balance_sheet (quarterly, 2025-06-30) — Current Capital Lease Obligation: 3001000.00
CDXS balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 3001000.00
CDXS balance_sheet (quarterly, 2025-06-30) — Current Deferred Liabilities: 100000.00
CDXS balance_sheet (quarterly, 2025-06-30) — Current Deferred Revenue: 100000.00
CDXS balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 15237000.00
CDXS cash_flow (quarterly, 2025-06-30) — Depreciation: 2066000.00
CDXS cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 2066000.00
CDXS cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 2066000.00
CDXS income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 85389000.00
CDXS income_statement (quarterly, 2025-06-30) — Diluted EPS: -0.16
CDXS income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: -13272000.00
CDXS income_statement (quarterly, 2025-06-30) — EBIT: -12278000.00
CDXS income_statement (quarterly, 2025-06-30) — EBITDA: -10212000.00
CDXS cash_flow (quarterly, 2025-06-30) — End Cash Position: 28325000.00
CDXS cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: 26774000.00
CDXS balance_sheet (quarterly, 2025-06-30) — Finished Goods: 1945000.00
CDXS cash_flow (quarterly, 2025-06-30) — Free Cash Flow: -20481000.00
CDXS balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: -3000.00
CDXS balance_sheet (quarterly, 2025-06-30) — Goodwill: 2463000.00
CDXS balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 2463000.00
CDXS balance_sheet (quarterly, 2025-06-30) — Gross PPE: 85022000.00
CDXS income_statement (quarterly, 2025-06-30) — Gross Profit: 13230000.00
CDXS income_statement (quarterly, 2025-06-30) — Impairment Of Capital Assets: 0.00
CDXS cash_flow (quarterly, 2025-06-30) — Income Tax Paid Supplemental Data: 0.00
CDXS income_statement (quarterly, 2025-06-30) — Interest Expense: 984000.00
CDXS income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 984000.00
CDXS income_statement (quarterly, 2025-06-30) — Interest Income: 584000.00
CDXS income_statement (quarterly, 2025-06-30) — Interest Income Non Operating: 584000.00
CDXS cash_flow (quarterly, 2025-06-30) — Interest Paid Supplemental Data: 908000.00
CDXS balance_sheet (quarterly, 2025-06-30) — Inventory: 1945000.00
CDXS balance_sheet (quarterly, 2025-06-30) — Invested Capital: 95004000.00
CDXS cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -367000.00
CDXS balance_sheet (quarterly, 2025-06-30) — Investmentin Financial Assets: 2798000.00
CDXS balance_sheet (quarterly, 2025-06-30) — Investments And Advances: 2798000.00
CDXS cash_flow (quarterly, 2025-06-30) — Issuance Of Debt: 9897000.00
CDXS balance_sheet (quarterly, 2025-06-30) — Leases: 15105000.00
CDXS balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 26606000.00
CDXS balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 39373000.00
CDXS balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 65979000.00
CDXS cash_flow (quarterly, 2025-06-30) — Long Term Debt Issuance: 9897000.00
CDXS balance_sheet (quarterly, 2025-06-30) — Machinery Furniture Equipment: 3724000.00
CDXS balance_sheet (quarterly, 2025-06-30) — Net Debt: 12612000.00
CDXS income_statement (quarterly, 2025-06-30) — Net Income: -13272000.00
CDXS income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: -13272000.00
CDXS income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: -13272000.00
CDXS income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: -13272000.00
CDXS income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: -13272000.00
CDXS cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: -13272000.00
CDXS income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: -13272000.00
CDXS income_statement (quarterly, 2025-06-30) — Net Interest Income: -400000.00
CDXS cash_flow (quarterly, 2025-06-30) — Net Investment Purchase And Sale: 2143000.00
CDXS cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: 9897000.00
CDXS cash_flow (quarterly, 2025-06-30) — Net Long Term Debt Issuance: 9897000.00
CDXS income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -400000.00
CDXS cash_flow (quarterly, 2025-06-30) — Net Other Financing Charges: -708000.00
CDXS balance_sheet (quarterly, 2025-06-30) — Net PPE: 42244000.00
CDXS cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -2510000.00
CDXS balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 53168000.00
CDXS balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Liabilities: 100000.00
CDXS balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Revenue: 100000.00
CDXS income_statement (quarterly, 2025-06-30) — Normalized EBITDA: -10212000.00
CDXS income_statement (quarterly, 2025-06-30) — Normalized Income: -13272000.00
CDXS cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: -17967000.00
CDXS income_statement (quarterly, 2025-06-30) — Operating Income: -12862000.00
CDXS income_statement (quarterly, 2025-06-30) — Operating Revenue: 15328000.00
CDXS balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 90254000.00
CDXS balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 3469000.00
CDXS balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: -3000.00
CDXS cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: 294000.00
CDXS balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 2012000.00
CDXS balance_sheet (quarterly, 2025-06-30) — Other Non Current Liabilities: 1299000.00
CDXS balance_sheet (quarterly, 2025-06-30) — Other Properties: 65191000.00
CDXS balance_sheet (quarterly, 2025-06-30) — Other Receivables: 4261000.00
CDXS balance_sheet (quarterly, 2025-06-30) — Other Short Term Investments: 39569000.00
CDXS balance_sheet (quarterly, 2025-06-30) — Payables: 1468000.00
CDXS balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 4874000.00
CDXS balance_sheet (quarterly, 2025-06-30) — Pensionand Other Post Retirement Benefit Plans Current: 7262000.00
CDXS balance_sheet (quarterly, 2025-06-30) — Preferred Stock: 0.00
CDXS income_statement (quarterly, 2025-06-30) — Pretax Income: -13262000.00
CDXS cash_flow (quarterly, 2025-06-30) — Proceeds From Stock Option Exercised: 317000.00
CDXS balance_sheet (quarterly, 2025-06-30) — Properties: 0.00
CDXS cash_flow (quarterly, 2025-06-30) — Provisionand Write Offof Assets: 0.00
CDXS cash_flow (quarterly, 2025-06-30) — Purchase Of Investment: -13857000.00
CDXS cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -2514000.00
CDXS balance_sheet (quarterly, 2025-06-30) — Receivables: 16483000.00
CDXS balance_sheet (quarterly, 2025-06-30) — Receivables Adjustments Allowances: -49000.00
CDXS income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 2098000.00
CDXS income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 2066000.00
CDXS income_statement (quarterly, 2025-06-30) — Research And Development: 13775000.00
CDXS balance_sheet (quarterly, 2025-06-30) — Restricted Cash: 502000.00
CDXS balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -596766000.00
CDXS cash_flow (quarterly, 2025-06-30) — Sale Of Investment: 16000000.00
CDXS cash_flow (quarterly, 2025-06-30) — Sale Of PPE: 3000.00
CDXS income_statement (quarterly, 2025-06-30) — Selling General And Administration: 12317000.00
CDXS balance_sheet (quarterly, 2025-06-30) — Share Issued: 90254000.00
CDXS income_statement (quarterly, 2025-06-30) — Special Income Charges: 0.00
CDXS cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 2532000.00
CDXS balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 55631000.00
CDXS balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 53168000.00
CDXS income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
CDXS income_statement (quarterly, 2025-06-30) — Tax Provision: 10000.00
CDXS income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.21
CDXS balance_sheet (quarterly, 2025-06-30) — Total Assets: 138246000.00
CDXS balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 95004000.00
CDXS balance_sheet (quarterly, 2025-06-30) — Total Debt: 68980000.00
CDXS balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 55631000.00
CDXS income_statement (quarterly, 2025-06-30) — Total Expenses: 28190000.00
CDXS balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 82615000.00
CDXS balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 49517000.00
CDXS balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 67378000.00
CDXS income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: -12862000.00
CDXS income_statement (quarterly, 2025-06-30) — Total Unusual Items: 0.00
CDXS income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: 0.00
CDXS balance_sheet (quarterly, 2025-06-30) — Work In Process: 0.00
CDXS balance_sheet (quarterly, 2025-06-30) — Working Capital: 73492000.00
CDXS income_statement (quarterly, 2025-09-30) — +Operating Expense: 25085000.00
CDXS income_statement (quarterly, 2025-09-30) — +Total Revenue: 8601000.00
CDXS balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 2425000.00
CDXS balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 6030000.00
CDXS balance_sheet (quarterly, 2025-09-30) — Accumulated Depreciation: -44008000.00
CDXS balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 654904000.00
CDXS cash_flow (quarterly, 2025-09-30) — Amortization Of Securities: -334000.00
CDXS cash_flow (quarterly, 2025-09-30) — Asset Impairment Charge: 0.00
CDXS balance_sheet (quarterly, 2025-09-30) — Available For Sale Securities: 2798000.00
CDXS income_statement (quarterly, 2025-09-30) — Basic Average Shares: 90251000.00
CDXS income_statement (quarterly, 2025-09-30) — Basic EPS: -0.22
CDXS cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 28325000.00
CDXS cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -182000.00
CDXS balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 28892000.00
CDXS balance_sheet (quarterly, 2025-09-30) — Capital Stock: 9000.00
CDXS balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 25351000.00
CDXS balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 58701000.00
CDXS balance_sheet (quarterly, 2025-09-30) — Cash Equivalents: 19161000.00
CDXS balance_sheet (quarterly, 2025-09-30) — Cash Financial: 6190000.00
CDXS cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: -111000.00
CDXS cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: 6387000.00
CDXS cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: -7703000.00
CDXS cash_flow (quarterly, 2025-09-30) — Change In Account Payable: 905000.00
CDXS cash_flow (quarterly, 2025-09-30) — Change In Inventory: 9000.00
CDXS cash_flow (quarterly, 2025-09-30) — Change In Other Current Assets: 6706000.00
CDXS cash_flow (quarterly, 2025-09-30) — Change In Other Current Liabilities: -792000.00
CDXS cash_flow (quarterly, 2025-09-30) — Change In Other Working Capital: 2179000.00
CDXS cash_flow (quarterly, 2025-09-30) — Change In Payable: 905000.00
CDXS cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: 905000.00
CDXS cash_flow (quarterly, 2025-09-30) — Change In Prepaid Assets: -1725000.00
CDXS cash_flow (quarterly, 2025-09-30) — Change In Working Capital: 7282000.00
CDXS cash_flow (quarterly, 2025-09-30) — Changes In Cash: -1427000.00
CDXS balance_sheet (quarterly, 2025-09-30) — Common Stock: 9000.00
CDXS balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 38544000.00
CDXS cash_flow (quarterly, 2025-09-30) — Common Stock Issuance: 0.00
CDXS balance_sheet (quarterly, 2025-09-30) — Construction In Progress: 770000.00
CDXS income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 2465000.00
CDXS balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 2987000.00
CDXS balance_sheet (quarterly, 2025-09-30) — Current Assets: 76192000.00
CDXS balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 3091000.00
CDXS balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 3091000.00
CDXS balance_sheet (quarterly, 2025-09-30) — Current Deferred Liabilities: 296000.00
CDXS balance_sheet (quarterly, 2025-09-30) — Current Deferred Revenue: 296000.00
CDXS balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 18475000.00
CDXS cash_flow (quarterly, 2025-09-30) — Depreciation: 2094000.00
CDXS cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 2094000.00
CDXS cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 2094000.00
CDXS income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 90251000.00
CDXS income_statement (quarterly, 2025-09-30) — Diluted EPS: -0.22
CDXS income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: -19615000.00
CDXS income_statement (quarterly, 2025-09-30) — EBIT: -18315000.00
CDXS income_statement (quarterly, 2025-09-30) — EBITDA: -16221000.00
CDXS cash_flow (quarterly, 2025-09-30) — End Cash Position: 26898000.00
CDXS cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: -111000.00
CDXS balance_sheet (quarterly, 2025-09-30) — Finished Goods: 1922000.00
CDXS cash_flow (quarterly, 2025-09-30) — Free Cash Flow: -7885000.00
CDXS balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: 12000.00
CDXS balance_sheet (quarterly, 2025-09-30) — Goodwill: 2463000.00
CDXS balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 2463000.00
CDXS balance_sheet (quarterly, 2025-09-30) — Gross PPE: 84542000.00
CDXS income_statement (quarterly, 2025-09-30) — Gross Profit: 6136000.00
CDXS income_statement (quarterly, 2025-09-30) — Impairment Of Capital Assets: 0.00
CDXS cash_flow (quarterly, 2025-09-30) — Income Tax Paid Supplemental Data: 0.00
CDXS income_statement (quarterly, 2025-09-30) — Interest Expense: 1292000.00
CDXS income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 1292000.00
CDXS income_statement (quarterly, 2025-09-30) — Interest Income: 634000.00
CDXS income_statement (quarterly, 2025-09-30) — Interest Income Non Operating: 634000.00
CDXS cash_flow (quarterly, 2025-09-30) — Interest Paid Supplemental Data: 902000.00
CDXS balance_sheet (quarterly, 2025-09-30) — Inventory: 1936000.00
CDXS balance_sheet (quarterly, 2025-09-30) — Invested Capital: 78273000.00
CDXS cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: 6387000.00
CDXS balance_sheet (quarterly, 2025-09-30) — Investmentin Financial Assets: 2798000.00
CDXS balance_sheet (quarterly, 2025-09-30) — Investments And Advances: 2798000.00
CDXS cash_flow (quarterly, 2025-09-30) — Issuance Of Capital Stock: 0.00
CDXS cash_flow (quarterly, 2025-09-30) — Issuance Of Debt: 0.00
CDXS balance_sheet (quarterly, 2025-09-30) — Leases: 15122000.00
CDXS balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 25801000.00
CDXS balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 39729000.00
CDXS balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 65530000.00
CDXS cash_flow (quarterly, 2025-09-30) — Long Term Debt Issuance: 0.00
CDXS balance_sheet (quarterly, 2025-09-30) — Machinery Furniture Equipment: 3765000.00
CDXS cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: 0.00
CDXS balance_sheet (quarterly, 2025-09-30) — Net Debt: 14378000.00
CDXS income_statement (quarterly, 2025-09-30) — Net Income: -19615000.00
CDXS income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: -19615000.00
CDXS income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: -19615000.00
CDXS income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: -19615000.00
CDXS income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: -19615000.00
CDXS cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: -19615000.00
CDXS income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: -19615000.00
CDXS income_statement (quarterly, 2025-09-30) — Net Interest Income: -658000.00
CDXS cash_flow (quarterly, 2025-09-30) — Net Investment Purchase And Sale: 6568000.00
CDXS cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: 0.00
CDXS cash_flow (quarterly, 2025-09-30) — Net Long Term Debt Issuance: 0.00
CDXS income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -658000.00
CDXS cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: -111000.00
CDXS balance_sheet (quarterly, 2025-09-30) — Net PPE: 40534000.00
CDXS cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -181000.00
CDXS balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 36081000.00
CDXS balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Liabilities: 100000.00
CDXS balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Revenue: 100000.00
CDXS income_statement (quarterly, 2025-09-30) — Normalized EBITDA: -16221000.00
CDXS income_statement (quarterly, 2025-09-30) — Normalized Income: -19615000.00
CDXS cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: -7703000.00
CDXS income_statement (quarterly, 2025-09-30) — Operating Income: -18949000.00
CDXS income_statement (quarterly, 2025-09-30) — Operating Revenue: 8601000.00
CDXS balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 90281000.00
CDXS balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 5337000.00
CDXS balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: 12000.00
CDXS cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: 357000.00
CDXS balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 1974000.00
CDXS balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 1312000.00
CDXS balance_sheet (quarterly, 2025-09-30) — Other Properties: 64885000.00
CDXS balance_sheet (quarterly, 2025-09-30) — Other Receivables: 3752000.00
CDXS balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 33350000.00
CDXS balance_sheet (quarterly, 2025-09-30) — Payables: 2425000.00
CDXS balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 5412000.00
CDXS balance_sheet (quarterly, 2025-09-30) — Pensionand Other Post Retirement Benefit Plans Current: 9676000.00
CDXS balance_sheet (quarterly, 2025-09-30) — Preferred Stock: 0.00
CDXS income_statement (quarterly, 2025-09-30) — Pretax Income: -19607000.00
CDXS cash_flow (quarterly, 2025-09-30) — Proceeds From Stock Option Exercised: 0.00
CDXS balance_sheet (quarterly, 2025-09-30) — Properties: 0.00
CDXS cash_flow (quarterly, 2025-09-30) — Provisionand Write Offof Assets: 0.00
CDXS cash_flow (quarterly, 2025-09-30) — Purchase Of Investment: -17708000.00
CDXS cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -182000.00
CDXS balance_sheet (quarterly, 2025-09-30) — Receivables: 9733000.00
CDXS balance_sheet (quarterly, 2025-09-30) — Receivables Adjustments Allowances: -49000.00
CDXS income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 2465000.00
CDXS income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 2094000.00
CDXS income_statement (quarterly, 2025-09-30) — Research And Development: 13868000.00
CDXS balance_sheet (quarterly, 2025-09-30) — Restricted Cash: 485000.00
CDXS balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -616381000.00
CDXS cash_flow (quarterly, 2025-09-30) — Sale Of Investment: 24276000.00
CDXS cash_flow (quarterly, 2025-09-30) — Sale Of PPE: 1000.00
CDXS income_statement (quarterly, 2025-09-30) — Selling General And Administration: 11217000.00
CDXS balance_sheet (quarterly, 2025-09-30) — Share Issued: 90281000.00
CDXS income_statement (quarterly, 2025-09-30) — Special Income Charges: 0.00
CDXS cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 2513000.00
CDXS balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 38544000.00
CDXS balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 36081000.00
CDXS income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
CDXS income_statement (quarterly, 2025-09-30) — Tax Provision: 8000.00
CDXS income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.21
CDXS balance_sheet (quarterly, 2025-09-30) — Total Assets: 123961000.00
CDXS balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 78273000.00
CDXS balance_sheet (quarterly, 2025-09-30) — Total Debt: 68621000.00
CDXS balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 38544000.00
CDXS income_statement (quarterly, 2025-09-30) — Total Expenses: 27550000.00
CDXS balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 85417000.00
CDXS balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 47769000.00
CDXS balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 66942000.00
CDXS income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: -18949000.00
CDXS income_statement (quarterly, 2025-09-30) — Total Unusual Items: 0.00
CDXS income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: 0.00
CDXS balance_sheet (quarterly, 2025-09-30) — Work In Process: 14000.00
CDXS balance_sheet (quarterly, 2025-09-30) — Working Capital: 57717000.00
CDXS income_statement (annual, 2025-12-31) — +Operating Expense: 99381000.00
CDXS income_statement (quarterly, 2025-12-31) — +Operating Expense: 22906000.00
CDXS income_statement (annual, 2025-12-31) — +Total Revenue: 70387000.00
CDXS income_statement (quarterly, 2025-12-31) — +Total Revenue: 38915000.00
CDXS balance_sheet (annual, 2025-12-31) — Accounts Payable: 1554000.00
CDXS balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 1554000.00
CDXS balance_sheet (annual, 2025-12-31) — Accounts Receivable: 8757000.00
CDXS balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 8757000.00
CDXS balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -45242000.00
CDXS balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -45242000.00
CDXS balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 657292000.00
CDXS balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 657292000.00
CDXS balance_sheet (annual, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -43000.00
CDXS balance_sheet (quarterly, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -43000.00
CDXS cash_flow (annual, 2025-12-31) — Amortization Of Securities: -1234000.00
CDXS cash_flow (quarterly, 2025-12-31) — Amortization Of Securities: -303000.00
CDXS cash_flow (annual, 2025-12-31) — Asset Impairment Charge: 3344000.00
CDXS cash_flow (quarterly, 2025-12-31) — Asset Impairment Charge: 3344000.00
CDXS balance_sheet (annual, 2025-12-31) — Available For Sale Securities: 2498000.00
CDXS balance_sheet (quarterly, 2025-12-31) — Available For Sale Securities: 2498000.00
CDXS income_statement (annual, 2025-12-31) — Basic Average Shares: 87142000.00
CDXS income_statement (quarterly, 2025-12-31) — Basic Average Shares: 90396000.00
CDXS income_statement (annual, 2025-12-31) — Basic EPS: -0.50
CDXS income_statement (quarterly, 2025-12-31) — Basic EPS: 0.11
CDXS cash_flow (annual, 2025-12-31) — Beginning Cash Position: 20829000.00
CDXS cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 26898000.00
CDXS cash_flow (annual, 2025-12-31) — Capital Expenditure: -4471000.00
CDXS cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -520000.00
CDXS balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 33103000.00
CDXS balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 33103000.00
CDXS balance_sheet (annual, 2025-12-31) — Capital Stock: 9000.00
CDXS balance_sheet (quarterly, 2025-12-31) — Capital Stock: 9000.00
CDXS balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 50793000.00
CDXS balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 50793000.00
CDXS balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 78209000.00
CDXS balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 78209000.00
CDXS balance_sheet (annual, 2025-12-31) — Cash Equivalents: 20145000.00
CDXS balance_sheet (quarterly, 2025-12-31) — Cash Equivalents: 20145000.00
CDXS balance_sheet (annual, 2025-12-31) — Cash Financial: 30648000.00
CDXS balance_sheet (quarterly, 2025-12-31) — Cash Financial: 30648000.00
CDXS cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: 27928000.00